BioTech Achillion Pharmaceuticals, Inc. Fourth Quarter 2013 Earnings Uneventful; Nuke Data in Third Quarter 2014 Is Key Catalyst of the YearBy Ryan WallaceMarch 19, 2014 Achillion Pharmaceuticals, Inc. reported net loss for the quarter of $13.4 million with a per-share loss of $0.14 versus our…